The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.
about
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recoveryIdentification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitorsFunctional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetusesThe impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogensMenstrual physiology: implications for endometrial pathology and beyondNeutrophils and inflammatory resolution in the mucosaThe hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regenerationThe pleiotropic effects of erythropoietin in infection and inflammationAttenuating myocardial ischemia by targeting A2B adenosine receptorsHypoxia-inducible factors in physiology and medicineActions of adenosine on cullin neddylation: implications for inflammatory responsesHypoxia: an alarm signal during intestinal inflammationMolecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseasesHypoxia-induced responses by endothelial colony-forming cells are modulated by placental growth factor.Up-regulation of hypoxia-inducible factor 1 alpha and hemodynamic responses following massive small bowel resection.Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia.Effect of proline analogues on activity of human prolyl hydroxylase and the regulation of HIF signal transduction pathway.Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection.Adenosine: an old drug newly discovered.IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1βNeuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage.Contributions of neutrophils to resolution of mucosal inflammation.Metabolic shifts in immunity and inflammation.Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammationBoosting the hypoxia-induced adaptive response in inflammatory bowel disease: a novel concept of treatment.Purinergic signaling during inflammation.Activation of Hif1α by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity.Hypoxia-inducible factor/MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of occludin, leading to hypoxia-induced inflammation.PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2.Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammationHIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury.Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells.The prolyl hydroxylase inhibitor dimethyloxalylglycine enhances dentin sialophoshoprotein expression through VEGF-induced Runx2 stabilizationHypoxia-inducible factor activation protects the kidney from gentamicin-induced acute injury.Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseasesBiological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury.Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis.Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury.
P2860
Q24620924-9CBD5864-7ED9-4C5F-BB71-4206973B9F54Q24624488-2F0672ED-4F5C-4337-A26D-572BF513E9D2Q24654648-82E037D1-CAE4-447B-97A5-4105F8AF9F1AQ26752794-487F283D-D0AD-4AA7-BCA7-6228E2347495Q26800993-F3D749E2-B1D4-45BE-8B7A-F3DB5AAD12C0Q26827177-DEF3F939-9E95-4C26-8693-83A23F2579E7Q26861237-263B6359-15F6-40E5-AACD-01E99BD4A4CAQ26864149-8A6D82CB-79D2-4F95-99B8-1283C2E4559FQ27006863-3EC497CA-CA94-450A-85D3-47C498FD7673Q27013770-1CA09AC0-185B-4C66-B38D-9823AB7F7545Q27690825-A1071630-FCF6-46A9-83D9-CFB14A783207Q27691319-F9631B32-0A4B-42FA-BF4B-5BF0BBB6C20EQ28297656-F372E22B-967B-4763-A655-3A9014879FF2Q30368149-E719E7D8-9357-47E6-9172-B5CD22023478Q30437625-8A8D5A80-9CEC-47E8-ABF6-69DBE84C54E5Q30492111-AFB70A98-83DF-4991-99D3-3C297DF028FBQ31159179-B69948D5-E497-4196-9378-A16A058EF470Q33374284-35F0EAE8-72DA-47FB-8209-59EE8431A170Q33555006-84534040-F520-4E1F-B725-DBAE7D62D891Q33692318-17D57D42-8581-4C35-8A01-931F75434E2CQ33711010-F110FC74-0F42-4F48-8758-12C5763EEF7DQ33719500-C51A7899-C8AF-4A3F-B81F-790422B317B9Q33829813-DDFA983C-6D86-4FC4-9A85-1F2A9DD5CB85Q33830064-A7270B15-FB3C-4401-A096-C42CC0F7C266Q33989082-6B6A8772-6142-49AD-BB41-2259F078B7EBQ34034751-54AF6A0E-6FFD-4448-BA62-204B3D305161Q34053479-F674E63F-8A9A-441E-A772-E31AEE03A85EQ34056540-1F9ADC13-F892-492C-8B40-22D406AD29C6Q34060109-FEFD1504-1474-49FA-9E2A-84D889B10D72Q34069514-4E2894A0-C625-4993-9A27-39E19DF3B33EQ34184568-748F0760-E07E-44C8-9AF9-D1E37AF6A3BAQ34212051-5EAE5C43-C04D-4EDD-968F-38335DE1001FQ34374873-D57DE593-66F8-4CA6-9CEA-8D145FDA322EQ34450143-3E1775A4-75F1-40EA-921B-4ACE7C81733EQ34473806-2EA3BF1D-B0B4-4C36-BD52-DE255098806DQ34657382-7FED464A-2AC1-424F-8197-71932C39CBE7Q34703746-D04D7DF7-4949-4D96-AD7B-E3B408B71B98Q34717238-CC2A90F7-3AB2-40CF-9AED-DBB0797947C2Q34977591-EEEA55C2-BA20-4A2F-86AB-98C56EF3004EQ34979942-D1E914E9-CC83-43D8-9B5C-CD1B82BE38AD
P2860
The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The hydroxylase inhibitor dime ...... in a murine model of colitis.
@en
The hydroxylase inhibitor dime ...... in a murine model of colitis.
@nl
type
label
The hydroxylase inhibitor dime ...... in a murine model of colitis.
@en
The hydroxylase inhibitor dime ...... in a murine model of colitis.
@nl
prefLabel
The hydroxylase inhibitor dime ...... in a murine model of colitis.
@en
The hydroxylase inhibitor dime ...... in a murine model of colitis.
@nl
P50
P1433
P1476
The hydroxylase inhibitor dime ...... e in a murine model of colitis
@en
P2093
Fergal Seeballuck
P304
P356
10.1053/J.GASTRO.2007.10.012
P407
P577
2007-10-10T00:00:00Z